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a b s t r a c t
Maladaptive mechanisms of pain processing in chronic pain conditions (CP) are poorly understood. We
used coordinate based meta-analysis of 266 fMRI pain studies to study functional brain reorganisation
in CP and experimental models of hyperalgesia.
The pattern of nociceptive brain activationwas similar in CP, hyperalgesia and normalgesia in controls.
However, elevated likelihood of activation was detected in the left putamen, left frontal gyrus and right
insula in CP comparing stimuli of the most painful vs. other site. Meta-analysis of contrast maps showed
no difference between CP, controls, mood conditions. In contrast, experimental hyperalgesia induced
stronger activation in the bilateral insula, left cingulate and right frontal gyrus.oordinate based meta-analysis
yperalgesia
eural pain signature
Activation likelihood maps support a shared neural pain signature of cutaneous nociception in CP and
controls. We also present a double dissociation between neural correlates of transient and persistent
pain sensitisation with general increased activation intensity but unchanged pattern in experimental
hyperalgesia and, by contrast, focally increased activation likelihood, but unchanged intensity, in CP
when stimulated at the most painful body part.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
ontents
1. Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 121
2. Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 122
2.1. Study inclusion and data selection . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 122
2.2. Data extraction and pre-processing . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 122
2.3. Coordinate based meta-analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 123
2.4. Contrast meta-analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 123
2.5. An omnibus test of differences between two activation patterns . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 123
2.6. Experimental procedure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 123
2.6.1. Study and data quality control . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 123
2.6.2. Statistics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 123
2.6.3. Comparing activation pattern between groups . . . . . . . . . .
2.7. Experimental factors affecting the neural pain response pattern . .
2.8. Neural pain response pattern in CP and HC . . . . . . . . . . . . . . . . . . . . . . . .
∗ Corresponding author at: Sir Peter Mansﬁeld Imaging Centre, Arthritis Research UK
ottingham, Queen’s Medical Centre, Derby Rd., Nottingham, NG7 2UH, UK.
E-mail address: dorothee.auer@nottingham.ac.uk (D.P. Auer).
1 These authors contributed equally to this work.
2 Current address: Department of Neurology, Neurosurgery and Psychiatry, University
ttp://dx.doi.org/10.1016/j.neubiorev.2016.04.001
149-7634/© 2016 The Authors. Published by Elsevier Ltd. This is an open access article u. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 123
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .123
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 124
Pain Centre, Division of Clinical Neuroscience, School of Medicine, University of
of Medicine and Pharmacy Carol Davila, Colentina Hospital, Bucharest, Romania.
nder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
R. Tanasescu et al. / Neuroscience and Biobehavioral Reviews 68 (2016) 120–133 121
2.9. Differences in the pain response pattern between CP and HC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 124
2.9.1. Is functional reorganisation in CP limited to neuropathic pain? . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 124
2.9.2. Can functional reorganisation in CP be modelled by hyperalgesia in HC? . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 125
2.9.3. Can functional reorganisation in CP be modelled by low mood in HC? . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 125
3. Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 125
3.1. Experimental factors affecting the neural pain response pattern . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .125
3.2. The neural pain response pattern in chronic pain patients and in healthy controls . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .126
3.3. Does the neural pain response pattern differ between CP and HC? . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 126
3.3.1. Is functional reorganisation in CP limited to neuropathic pain? . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 127
3.3.2. Can functional reorganisation in CP be modelled by hyperalgesia in HC? . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 129
3.3.3. MAC of hyperalgesia vs. normalgesia in HC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 129
3.3.4. Can functional reorganisation in CP be modelled by low mood in HC? . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 129
4. Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 129
5. Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 132
Appendix A. Supplementary data . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 132
. . . . . .
1
t
p
t
(
s
t
t
2
f
c
b
b
p
t
t
c
a
t
a
i
u
t
p
g
n
t
d
n
s
e
d
2
e
c
ﬁ
c
h
l
i
a
d
s
aReferences . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. Introduction
Chronic pain is a common public health concern. According
o a report by Mantyselka et al. (2001), pain accounts for 40% of
rimary care consultations. A survey of adult Europeans found
hat the prevalence of moderate or severe chronic pain was 19%
Breivik et al., 2006), of whom 21% were diagnosed with depres-
ion related to their pain and 65% reported sleep disturbance due
o pain (Breivik et al., 2006). Severe chronic pain was also found
o be associated with increased 10 year mortality (Torrance et al.,
010). In the absence ofmore effective pain treatment personal suf-
ering and socio-economic burden are huge, with the total annual
ost of pain in the US estimated to be between $560 and $635
illion (Gaskin and Richard, 2012). This highlights the need for
etter understanding of the neural mechanisms underpinning the
rocessing of chronic pain in order to begin addressing this issue.
Presently there is no clear temporal deﬁnition of when persis-
ent pain is considered to be ‘chronic’. However, there is consensus
hat chronic pain refers to pain persisting beyond its ecologi-
al alerting function, (i.e. when no beneﬁt from healing can be
ssumed). As such chronic pain is considered a maladaptive state
hat is characterised not only by pain severity but also by a range of
ssociated comorbidities including depression, distress and anx-
ety. A detailed taxonomy based upon symptom description and
nderlying etiology has been developed and recently updated by
he International Association for the Study of Pain (www.iasp-
ain.org/Taxonomy). Several etiological factors are coded, and in
eneral nociceptive pain is distinguished from neuropathic pain:
ociceptive pain involves activationof nociceptors throughactual or
hreatened non-neural tissue damage, whereas neuropathic pain is
eﬁned as ‘pain caused by a lesion or disease of the somatosensory
ervous system’ (www.iasp-pain.org/Taxonomy).
The pathophysiology of chronic pain states is not well under-
tood but there is a body of neurobiological and neuroimaging
vidence suggesting that neuroplasticity is associated with the
evelopment of persisting pain (Dickenson, 2011; Henry et al.,
011; Tracey and Bushnell, 2009; Woolf, 2011). In animal mod-
ls, several mechanisms of pain sensitisation were identiﬁed and
haracterised with peripheral sensitisation via activation of C-
bers, sodium channel alteration after nerve injury and central
ord sensitisation due to increased spinal transmitter release and
yperexcitability of dorsal horn neurons (Dickenson, 2011). Modu-
ation of stimulus-induced pain perception at the supraspinal level
s highly complexwith close interconnection of sensory, emotional
nd cognitive appraisal networks. Moreover, a key serotonergic
escending facilitation pathway originates from the rostral brain-
tem and is believed to mediate fear and anxiety-related pain
ugmentation (Dickenson, 2011). Increasedpain sensitivity (hyper-. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 132
algesia) is well known in chronic pain patients (CP) resulting from
a combination of peripheral and central sensitisation at the spinal
cord level and supraspinal pain augmentation/facilitation (Woolf,
2011).
Central sensitization canbemodelled inhealthyhumancontrols
through priming, e.g. with intradermal capsaicin (active ingredient
in chili, a TRPV1 receptor agonist), which leads to cross-modality
hyperalgesia and allodynia (pain from non-noxious stimuli). The
underlying neurophysiology is well characterised, and thought to
reﬂect transient heterosynaptic changesmaking experimental cen-
tral sensitisation a sound mechanistic model to test efﬁcacy of
centrally acting analgesics (Woolf, 2011). By contrast, top-down
facilitatory processes are less well understood and robust experi-
mental human models are lacking. Nevertheless, depression and
low mood are commonly associated with chronic pain, and are
thought to contribute to central pain augmentation and severity.
Several studies have found that induction of depressed mood or
sadness in healthy subjects increases pain sensitivity and augments
pain unpleasantness (Berna et al., 2010; Pinerua-Shuhaibar et al.,
2011; Villemure and Bushnell, 2009).
Modern functional neuroimaging has proved instrumental in
gaining a deeper understanding of pain processing and its main
modulatory factors inhealthyvolunteers (Baliki et al., 2007; Leeand
Tracey, 2013) and chronic pain conditions. In line with the multi-
dimensional nature of pain perception, experimental pain induces
activation in several cortical and subcortical regions including pri-
mary (S1) and secondary (S2) somatosensory cortices, insula (INS),
anterior cingulate cortex (ACC), thalamus, brainstemandprefrontal
and parietal association areas (Melzack, 2001). These structures,
often referred to as the ‘pain matrix’ (Melzack, 2005), do not con-
stitute a network that is unique to pain; in fact there are striking
similarities with activation patterns of innocuous sensory stimuli
(Iannetti and Mouraux, 2010). Consistent, but not pain speciﬁc,
co-activation may relate to any of the aspects of the pain experi-
ence including saliency of stimuli (Iannetti et al., 2013), emotional
responses (Hashmi et al., 2013) or action preparation (Perini et al.,
2013), all of which could bemodulated by chronic pain (Tracey and
Mantyh, 2007). Functional neuroimagingmight thereforebe ideally
suited to studying the functional reorganisation of bothnociceptive
and pain modulatory pathways in chronic pain syndromes, and to
relate putative plasticity changes to etiologic pain subtypes and
underlying mechanisms such as central sensitisation and negative
affect.
Functional MRI (fMRI) studies have shown altered neural
response to pain in CP compared tohealthy controls (HC), for exam-
ple (Baliki et al., 2006; Flor, 2003; Henderson et al., 2011; Napadow
et al., 2010; Schweinhardt et al., 2006; Wrigley et al., 2009). How-
ever, there is some inconsistency between studies. Systematic
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eviewsofferonemethodof exploringwhichof the reportedaltered
eural responses are consistently observed, for example more fre-
uent prefrontal, and less frequent ACC, S1, S2 and INS activation
as noted in CP (Apkarian et al., 2005; Peyron et al., 2000). Recently
oordinate based meta-analysis (CBMA) has become a popular
lternative. CBMA analyses the results from related studies and
erforms statistical inference on them. Probably the most com-
only used method computes an activation likelihood estimate
ALE) using the reported coordinates to identify and locate brain
tructures that are activated consistently across studies or differ-
ntly between conditions/groups. In this way CBMA can mitigate
owpower andbias present in individual fMRI studies (Button et al.,
013; Wager et al., 2007). Several CBMAs of pain have been per-
ormed (Amanzio et al., 2013; Duerden and Albanese, 2013; Friebel
t al., 2011; Lamm et al., 2011; Lanz et al., 2011; Simons et al.,
012). While some focused on general and modality-speciﬁc pain-
nduced changes in brain activity (Duerden and Albanese, 2013;
riebel et al., 2011; Lanz et al., 2011) others have studied the role
f speciﬁc structures (Simons et al., 2012) or context-dependent
ffects (Amanzio et al., 2013; Lamm et al., 2011). CBMA has also
een used to compare abnormal and altered pain states in CP or
xperimental hyperalgesia (Friebel et al., 2011; Lanz et al., 2011).
llodynia/hyperalgesia in chronic neuropathic and ﬁbromyalgia
atients was associated with increased activation likelihood in
he left S2, ACC and right caudal anterior insula compared to
xperimental pain in HC (Friebel et al., 2011) while neuropathic
ain decreased activation likelihood in most pain processing areas
ncluding S1, anterior and posterior insula and ACC compared to
xperimental hyperalgesia inHC (Lanz et al., 2011). There are, how-
ver, several methodological limitations of previous CBMA studies
f pain.We have previously shown that the ALEmethods are prone
o false positive results (Tanasescu et al., 2015; Tench et al., 2013),
nd a newversion of the software implementation (GingerALE, ver-
ion 2.3.3) has been released to ﬁx this. We have also shown that
he false positive rate can increase with increasing study numbers
Tench et al., 2014); the current ALE algorithm does not correct
or this. Furthermore, group comparisonsmake assumptions about
he ALE that do not strictly hold (Duerden and Albanese, 2013;
anz et al., 2011), or lack appropriate correction for the many sta-
istical tests performed (Friebel et al., 2011). A further limitation
s the uncontrolled heterogeneity between studies, often mixing
unctional neuroimagingmethods (known to vary in sensitivity) or
ixing a range of nociceptive receptor systems (superﬁcial, deep
nd visceral).
To better understand the commonalities of altered pain
rocessing in CP and any speciﬁc modulation related to its sub-
ypes, and importantly to compare activation patterns in CP with
xperimental models of putative underlying mechanisms of pain
ensitisation (hyperalgesia and low mood) in healthy controls, we
ndertook a CBMA on superﬁcial pain fMRI studies and systemat-
cally addressed key experimental factors. We hypothesised that
he neural response to experimental pain differs between CP and
C reﬂecting functional reorganisation, and that such changes can
e partiallymodelled by experimental hyperalgesia or lowmood in
ealthy controls. To overcome some of the limitations of previous
ain CBMAs we employ a recently developed modiﬁed ALE based
lgorithm that reduces false positive results by using an intuitive
ype 1 error control scheme: the false cluster discovery rate (FCDR;
imilar to false discovery rate, but for clusters) control (Tench et al.,
013). We employ the same control for the contrast meta-analysis
CMA) used to locate differences in functional activation foci due
o pain stimulus between groups (Tench et al., 2014). However,
his test is sensitive only to strong local differences, so we also use
n omnibus test that can detect subtle but distributed differences
n the pattern when CMA is unrevealing (Tench et al., 2014). This
est has also been used to explore differences due to experimentalhavioral Reviews 68 (2016) 120–133
factors, such as pain stimulus modality (thermal, mechanical and
electrical) to assess heterogeneity introduced by such factors. This,
plus careful, and conservative study selectionwas used to create, as
far as possible, homogeneous experimental groups. To this end, we
limit the CBMA to fMRI studies and to cutaneous noxious stimuli
thus eliminating unwanted heterogeneity from different imaging
modalities and different nociceptive systems (superﬁcial vs. deep
and visceral).
2. Methods
2.1. Study inclusion and data selection
The literature search was performed according to the PRISMA
guidelines for reporting meta-analyses and systematic reviews
(Moher et al., 2009). Functional MRI studies of experimental
cutaneous pain were searched both through standard literature
databases (PubMed andWebof Knowledge) and fromexisting fMRI
data repositoryNeuroSynth (neurosynth.org).NeuroSynth is aplat-
form for large-scale, automated synthesis of fMRI data extracted
from published articles (Yarkoni et al., 2011). We used the key-
words (“MRI” or “magnetic resonance imaging”) AND (“functional”
or “brain activation” or “neural activity” or “BOLD”) AND (“pain”
or “noxious” or “nociception” or “hyperalgesia” or “allodynia” or
“low mood” or “emotion”). In order to capture as many papers as
possible, including studies on CP, additional searches have been
performed using the strings (“MRI” or “magnetic resonance imag-
ing”) AND (“functional” or “brain activation” or “neural activity”
or “BOLD”) AND (“pain” or “noxious” or “nociception” or “hyper-
algesia” or “allodynia”)AND (“lowmood” or “emotion”), and (“MRI”
or “magnetic resonance imaging”) AND (“functional” or “brain acti-
vation” or “neural activity” or “BOLD”) AND (“pain” or “noxious”
or “nociception”) AND (“patients” or “neuropathic” or “chronic
pain” or “hyperalgesia” or “allodynia”). For the search on Neu-
roSynth repository we used the key word “pain”. Last accession
of e-sources: 15 February 2015. The references of retrieved articles
were then assessed for additional studies that could be considered
for inclusion; along with the relevant references from review arti-
cles and meta-analyses. Abstracts were reviewed to select those
studies involving noxious pain stimuli that had been induced via
cutaneous stimulation. Studies reporting only activations for spon-
taneous pain in patients were excluded. Only studies that reported
whole-braingroupanalysis as coordinates in the standardTalairach
& Tournoux or Montreal Neurological Institute (MNI) reference
spacewere considered (Evans et al., 1993; Talairach, 1988). Studies
on HC with or without pain sensitisation were included. In cases
where experimental pain was induced in addition to a cognitive
manipulation task we only included the baseline coordinates of
pain induction; if baseline coordinates were not given; the study
was excluded from further analysis.
2.2. Data extraction and pre-processing
Activation coordinates were extracted from the papers man-
ually and checked by three independent persons. Data extracted
from each article were the authors’ names, date of publication,
studypopulation, sample size, stimulusmodality, anatomical siteof
stimulation, laterality of bodily stimulation, brain activation coor-
dinates and their associated standardised space (Talairach orMNI).
Differences in the standardisedcoordinate spacewereaddressedby
converting all reported coordinates into Talairach space (Lancaster
et al., 2007).Weonly includedcoordinatesof activations sincedeac-
tivations were reported by few studies, and the majority of studies
did not comment on the presence or absence of deactivations.
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Importantly, we also extracted activation coordinates from
tudies of betweengroupcomparisons allowingus toperformcoor-
inate based meta-analysis of contrasts (MAC). Since such data
s generated under controlled experimental conditions, MAC pro-
ides a powerful way to explore spatially consistent differences in
ctivation intensity between the groups. This analysis is comple-
entary to the contrast meta-analysis, which explores differences
n consistency of reported structures, performed on similar groups.
Multiple studies reported in single papers can be strongly cor-
elated. This would result in bias if these studies were considered
ndependent (Turkeltaub et al., 2012). Toprevent this, the extracted
oordinates were merged into a single study if the paper reported
esults differing only by experimental factors such as different
timulus intensities, different body site stimulated, or data split
y analysis e.g. late/early BOLD response. Studies using different
ubjects were not merged.
Different studies reporting the same results also violate the
ssumption of independence. Instances of repeated coordinates
ere identiﬁed and removed to prevent bias.
.3. Coordinate based meta-analysis
Here we use a recently developed algorithm (LocalALE), which
s freely available from http://www.nottingham.ac.uk/research/
roups/clinicalneurology/neuroi.aspx. This algorithm utilizes the
oordinates from fMRI studies to estimate where there is con-
istently reported activation across studies. It is based on the
ommonly usedALE algorithm (Turkeltaub et al., 2002) that utilizes
Gaussian, with speciﬁed full width half max (FWHM), model for
ach coordinate to estimate the activation likelihood. When many
tudies report coordinates in a similar location, the activation like-
ihood is high; a threshold for statistical signiﬁcance is determined
y a permutation test. LocalALE has important advantages over the
ore commonly used ALE algorithm: (1) the false positive rate is
educed, and (2) by adjusting the FWHM, heterogeneity between
xperiments that have different numbers of studies is reduced
Tench et al., 2013; Tench et al., 2014). Anatomical placement of
igniﬁcant clusters was reported in Talairach space using an auto-
atic labelling scheme incorporated within LocalALE (Lancaster
t al., 2000).
.4. Contrast meta-analysis
Contrast meta-analysis is used to compare the reported activa-
ion foci between two groups, and has been described previously
Friebel et al., 2011). The results are clusters of coordinates where
he activation pattern differs signiﬁcantly between the groups. The
ull hypothesis is that the two groups report the same activation
attern. Permutation of the group variable is performed to esti-
ate a p-value for each coordinate. This differs from the previously
ublished scheme, where a p-value was estimated for each voxel;
ur scheme reduces the number of statistical tests performed by
everal orders of magnitude, and employs FCDR, to control type 1
rrors (Tench et al., 2014).
.5. An omnibus test of differences between two activation
atterns
Contrast meta-analysis is sensitive to localised spatial differ-
nces in activation pattern between two groups. These differences
eed to be highly signiﬁcant to survive correction for the multiple
tatistical tests performed. Consequently CMA is not sensitive to
ore subtle diffuse differences between the groups. Therefore, we
ave devised an omnibus test of difference in activation pattern
etween two groups (Tench et al., 2014).havioral Reviews 68 (2016) 120–133 123
The algorithm tests the combined p-values (sum, over coor-
dinates, of the log p-values) generated by CMA using a method
analogous to Fisher’s combined probability test; but without the
assumption of independent, uniformly distributed, p-values. It
achieves this by comparisonwithanull distributiongenerated from
similarly combined p-values obtained by performing CMA on 1000
random permutations of the grouping variable. This test differs
from CMA in that it requires not that single p-values be very small,
but that the combined p-values be critical of the null hypothesis;
this can occur when there is a diffuse pattern of subtle differences
resulting in multiple small p-values, or a focal highly signiﬁcant
difference affecting just a few p-values.
2.6. Experimental procedure
2.6.1. Study and data quality control
There is no consensusonminimumquality standards for, or how
toquantify thequalityof, functionalMRI studies.Many fMRI studies
are thought to be underpowered but there is no suitable formula
based e.g. on number of subjects to determine a clear cut-off as
the effect size for the chosen brain activation contrast will depend
on the chosen activation and control task, respective presentation
length and number of repeats in addition to technical factors such
asﬁeld strength, sensitivity of head coil, acquisitionprotocol details
and scanner-speciﬁc stability. Studieswere thus consideredeligible
for inclusionwhendescribing commonly used fMRI acquisition and
analysis protocols.
Importantly, we used the diagnostic procedure detailed in
(Tench et al., 2013) to check that studies appear commensurate in
their respective groups. How commensurate each study is with all
otherswas quantiﬁed by computing themean activation likelihood
across coordinates within the study, then comparing these to the
distribution of mean activation likelihood values generated using
an equal number of random coordinates; if the observedmeanwas
in the high tail of this distribution, the study was considered com-
mensurate. This test is sensitive to coordinate extraction errors
and was used to pinpoint outlying studies to be scrutinised fur-
ther and corrected as necessary. Further analysis was performed
only after checking that the data are correct, and that the studies
were included in the appropriate experimental group.
2.6.2. Statistics
The CBMA, and MAC, were performed using an FCDR of 0.05, so
of the signiﬁcant clusters identiﬁed at most 5% would be expected
under the null hypothesis. Contrast meta-analysis is less sensitive
and performed using an FCDR of 0.1. For primary analyses (HC vs.
CP) trends towards signiﬁcance are also noted. The omnibus test of
differences was considered signiﬁcant if p≤0.05.
2.6.3. Comparing activation pattern between groups
Comparisons of study groups were performed using three types
of analysis. Plotting the frequency with which the studies report
activations in each Talairach structure visually highlights where
the groups differ, and where they are similar; structures were
determined as the nearest grey matter Talairach structure to each
reported coordinate. Comparison of groups by CMA revealed clus-
ters of coordinates in locations where the activation patterns differ
statistically. If thiswas unrevealing, the omnibus test of differences
was used to more sensitively detect any differences, but without
revealing where those differences are.
2.7. Experimental factors affecting the neural pain response
pattern
To maximise statistical power experimental groups were cre-
ated to contain as many studies as possible. This involved merging
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Table 1
Study groups included in the CBMA (in grey: main groups; in white: sub-groups).
Group Detail Population Papers Studies Extracted Study numbers after merging Coordinates extracted Subjects
HC All HC HC 154 180 155 2780 2278
MECHHC Mechanical HC 24 28 25 391 325
THERMHC Thermal HC 104 120 104 1855 1520
ELECHC Electrical HC 28 33 30 534 453
RIGHTHC Right Stimulus HC 64 75 65 1200 951
LEFTHC Left Stimulus HC 77 85 79 1249 1176
RESTHC Pain vs. rest HC 76 91 78 1296 1128
INNOCHC Pain vs. innocuous HC 66 75 67 1216 912
CUEDHC Cued HC 33 36 34 577 587
NCUEDHC Non-cued HC 121 145 123 2199 1691
CP All CP CP 32 38 32 514 506
NEURCP Neuropathic CPP 16 21 16 322 177
MSKCP MSK CPP 8 9 8 125 122
FMCP FM CPP 8 9 8 81 207
CSCP Clinical Site CPP 16 19 16 321 192
OSCP Remote Site CPP 16 19 16 193 309
OS-FMCP As OS but excluding all FM studies CPP 8 11 8 126 102
ALDNCP Allodynic CPP 11 12 11 199 143
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oNOXCP Noxious CPP 23 27
MECHCP Mechanical CPP CPP 20 21
HYPERHC Hyperalgesia HC 9 11
ubgroups differing by experimental factors that might affect the
unctional response. Such differences would be a source of hetero-
eneity. The omnibus test was used here to explore such sources of
eterogeneity.
It has been suggested that the encoding of painful stimuli takes
lace primarily in the contralateral hemisphere to the stimulation
ite (Coghill et al., 1999). Mirroring the coordinates from left-sided
ody stimulation about the y-axis (multiplying the x coordinate by
1) would then maintain homogeneity across all studies, as long
s the hemispheric lateralization is of minor importance in pain
rocessing. Such mirroring has been used in a previous CBMA of
ain (Lanz et al., 2011), but has recently been challenged (Duerden
nd Albanese, 2013). We compared subgroups of HC, where the
rouping was right sided stimulation (subgroup RIGHTHC, Table 1)
nd left sided stimulation (subgroup LEFTHC, Table 1). The analy-
is was performed twice, once with original coordinates, and once
ith the coordinates mirrored in the left sided stimulus group. The
esults were used to determine whether mirroring of coordinates
as performed throughout all subsequent experiments.
Subgroups of HC studies by modality (electrical, mechanical,
nd thermal)were formed (subgroupsMECHHC, THERMHC, ELECHC;
able 1). HC studies were also grouped by baseline stimulus:
pain versus (vs.) innocuous stimuli’ and ‘pain vs. rest’ (subgroups
NNOCHC and RESTHC; Table 1), and by ‘cued’ and ‘non-cued’
timulation (subgroups CUEDHC and NCUEDHC; Table 1). Relevant
ubgroups were compared.
Pain sensitisation in CP may be affected by site and type (nox-
ous or allodynic) of stimulus. In the CP group, half of the studies
pplieda stimulusat themostpainful clinical site (CS)of the chronic
ain (CSCP subgroup; Table 1), while half used other bodily sites
OS) stimulation (OSCP subgroup; Table 1); because all ﬁbromyal-
ia (FM) studies included nociceptive stimulation remotely from
ny area reported by participants as being chronically painful (ﬁn-
er/thumb stimulation—6 studies; hand stimulation—2 studies),
e included the eight FM studies in the OSCP subgroup. To assess
he inﬂuence of FM studies on the results, comparison between CS
nd OSwas also performed excluding FM from the OS group (using
he omnibus test). Around one quarter of the CP studies used non-
oxious stimuli at the allodynic site (ALDNCP subgroup; Table 1)
hilst the rest used noxious painful stimuli (NOX subgroup;CP
able 1). These groups were compared by omnibus test. Moreover,
e explored the effect of matching pain intensity between groups
r conditions based on perceived pain intensity of stimulus inten-23 333 400
20 289 381
11 188 116
sity.We found that approximately half of the reported comparisons
of CP vs. HC and hyperalgesia vs. normalgesia (MAC’s) used stan-
dardised stimulus intensity (stimulus-matched paradigm)with the
other half of studies adapting stimulus intensity to standardise
perceived pain intensity (pain percept-matched paradigm). Due
to the small sample sizes and potential inhomogeneity between
these experiments, they were compared for differences using the
omnibus test.
2.8. Neural pain response pattern in CP and HC
Coordinate based meta-analysis was used to ﬁnd clusters of
coordinates due to painful stimuli in HC and CP groups. The nearest
Talairach structure to the centre of these clusters is reported, and
considered to be of functional relevance to pain processing. The
frequency with which each Talairach structure was reported was
evaluated.
2.9. Differences in the pain response pattern between CP and HC
The neural signature of pain in CP and HC subgroups were
compared using CMA to explore differences in activation patterns,
and using MAC to explore differences in activation intensity. It is
expected that the likelihood of activation shows signiﬁcant spa-
tial differences, reﬂecting functional reorganisation as previously
suggested (Baliki et al., 2006; Flor, 2003; Henderson et al., 2011;
Lanz et al., 2011; Napadow et al., 2010; Schweinhardt et al., 2006;
Wrigley et al., 2009). We furthermore expected MAC differences
related to hyperalgesia in CP.
2.9.1. Is functional reorganisation in CP limited to neuropathic
pain?
CP studieswere sub-groupedby etiology (neuropathic (NEURCP;
Table 1), nociceptive musculo-skeletal (MSKCP; Table 1), and
ﬁbromyalgia (FMCP; Table 1). There are distinct neurophysiological
differences between neuropathic and musculo-skeletal pain dis-
orders with controversies regarding the classiﬁcation of FMCP
(Phillips and Clauw, 2013; Rowbotham, 2005; Schnitzler and
Ploner, 2000). Thus, there may be differences in the functional
response to pain stimulation between these groups with the
expectation that neuropathic pain is characterised bymore promi-
nent functional reorganisation. Relevant comparisons were made
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Table 2
Study groups included in the coordinate based meta-analysis of contrasts (MAC), consisting of coordinates from fMRI studies of between-group comparisons.
Group Detail Population Papers Studies extracted Study numbers
after merging
Coordinates
extracted
Subjects
(no.)
CP HCMAC CP>HC activation
intensity
CP, HC 17 18 17 103 221
HYPER HCMAC Hyperalgesia >normalgesia
activation intensity
HC 9 11 9 146 121
HYPER CPMAC Hyperalgesia >normalgesia CP 3 3 3 38 26
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LM HCMAC Low mood HC 5
etween these subgroups using CMA and the omnibus test of dif-
erences between groups.
.9.2. Can functional reorganisation in CP be modelled by
yperalgesia in HC?
To assess whether functional reorganisation in CP is related
o peripheral and central sensitisation as putative mechanisms,
e studied the activation pattern speciﬁc to experimental hyper-
lgesia in healthy controls as a model of pain sensitisation. To this
nd we studied the pattern of pain processing in HC after experi-
ental induction of hyperalgesia (HYPERHC subgroup; Table 1) in
omparison with normalgesia by CBMA of the hyperalgesia group,
nd by CMA and MAC between hyperalgesia and normalgesia. The
requency of reporting brain structures activated in each group
as also explored. We expected signiﬁcantly increased likelihood
nd increased intensity of activation due to central sensitisation in
yperalgesia (Woolf, 2011).
.9.3. Can functional reorganisation in CP be modelled by low
ood in HC?
To assess whether functional reorganisation in CP can be mod-
lled by emotional status during painful stimulation, we studied
he activation pattern speciﬁc to low mood in healthy controls
nder painful stimulation. Due to incomplete study reporting, we
ere unable to perform CMA between normal and low mood.
nstead, we performed MAC of studies comparing painful stim-
lation with or without concomitant low mood condition (LMHC
ubgroup; Table 1). We expected to detect increase in activation
ntensity during the low mood condition in emotional circuits and
tructures contributing to central pain augmentation and chroniﬁ-
ation.
. Results
A total of 3815 reported coordinates of activation foci were
xtracted from 178 papers reporting on 266 fMRI studies of cuta-
eous experimental pain in 3014 subjects: 180 studies involved
C (2278 subjects; median 12, range 4–61 per study), and 38 stud-
es involved CP (506 subjects; median 12, range 5–83 per study)
see Table S1 in Supplementary Material for included studies and
ig. 1). Coordinates from experimental hyperalgesia in HC and CP
11 studies, 116 subjects; 3 studies, 26 subjects) and pain studies
n HC involving low mood induction (5 studies, 114 subjects) were
lso extracted.
The studies were divided into modality and condition-speciﬁc
ub datasets (Table 1). Relevant contrast data from 37 studies suit-
ble forMACwere available for extraction from34papers (Table 2).
Chronic pain patient conditions included neuropathic pain
yndromes (chronic regional pain syndrome, n =4, trigeminal
euralgia, n =1; burning mouth disorder, n =1; syringomyelia,
= 1; post-herpetic neuralgia, n =2; peripheral neuropathy n=3;
eadache, n =3; vulvar vestibulitis syndrome, n =1); primary
ociceptive musculo-skeletal disorders (low back pain, n =6;5 46 114
osteoarthritis, n =2) and ﬁbromyalgia (FM, n=8). We additionally
subdivided CP studies according to the site of the nociceptive stim-
ulation: at the most painful clinically affected site (CSCP; Table 1),
or at another body site (OSCP; Table 1).
3.1. Experimental factors affecting the neural pain response
pattern
SubgroupsofHCstudiesusing right sidedpain stimuli (RIGHTHC;
Table1) and left sidedpain stimuli (LEFTHC; Table1)were compared
using theomnibus test,with andwithoutmirroring the coordinates
in the latter group. The difference was signiﬁcant when compar-
ing the original coordinates (p=0.036), but much more so when
comparison was done using mirrored coordinates from the left
sided stimulus studies (p=0.002) demonstrating highly signiﬁcant
lateralisation of neural pain processing that cannot be neglected.
Consequently, all subsequent experiments used original coordi-
nates only.
The three different modalities of pain stimulation (mechani-
cal, electrical, thermal) showed largely overlappingbrain activation
patterns (data not shown). However, the omnibus test did suggest
some differences (mechanical vs. thermal: p=0.02; mechanical vs.
electrical: p=0.04; electrical vs. thermal: p=0.16).
We compared HC studies contrasting pain against rest (sub-
group RESTHC; Table 1) to studies contrasting pain against
innocuous sensory stimuli (subgroup INNOCHC; Table 1). No dif-
ferences were detected (p=0.6).
We also compared studies employing cued painful stimulation
(subgroup CUEDHC, Table 1) to non-cued painful stimulation (sub-
group NCUEDHC, Table 1). Again, no differences were observed
(p=0.13).
We compared the CP subgroup in which nociceptive stimulus
was applied to the site of maximal clinical pain (CSCP) to the CP
subgroup in which painful stimulus was applied remotely to that
site (OSCP). The OSCP subgroup included all eight FM studies, as
none used stimulation of most painful body sites. The stimulated
body parts in the two subgroups were: upper limb (CSCP 5 studies,
OSCP 13 studies), lower limb (CSCP 6 studies, OSCP 1 study), trunk
(3 studies—all CSCP), and head and face (3 studies in each group).
The omnibus test suggested some difference in activation pattern
between these groups (p=0.006).Wealso compared theCSCP group
with an OSCP group that excluded FM (OS-FMCP). The omnibus test
still indicated a difference in activation patterns between these
groups (p=0.03).
The design differences in matching CP and controls for pain
intensity were unlikely to have masked true group differences as a
comparison by omnibus test of perception versus stimulus inten-
sity matched studies revealed no difference (p=0.96). The same
was found for hyperalgesia vs. normalgesia contrasts revealing no
signiﬁcantly difference when comparing perception and stimulus
matched studies using the omnibus test (p=0.6).
We compared the CP subgroup employing allodynic pain
stimulus to the subgroup employing noxious stimuli; allodynic
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subgroupALDNCP; Table 1) vs. noxious (subgroupNOXCP; Table 1).
owever, we detected no signiﬁcant differences in the activation
ikelihood by omnibus test (p=0.46).
Aiming for large groups to increase power, subsequent exper-
ments included studies using electrical, thermal, and mechanical
odality types, rest and innocuous contrast conditions, cued and
on-cued painful stimulus, and perception and stimulus inten-
ity matched studies. However, the differences by pain stimulation
odality, andby site of stimulation in theCPgroup,maybe a source
f heterogeneity.
.2. The neural pain response pattern in chronic pain patients
nd in healthy controls
The CBMA of nociceptive brain activation in the HC group
evealed all ‘pain-matrix’ processing areas (thalamus, INS, cingu-
ate, PFC, S1, S2, parahippocampal gyrus, brainstem nuclei, basal
anglia, Fig. 2a, Table S2.1). No single structure is reported by all
tudies. Right and left posterior insula (BA13)were themost consis-
ent, each being reported in around 66% of studies. Other structures
f the pain matrix were also among the most frequently reported.
he bilateral BA40 (inferior parietal, S2) and left ACC (BA24) were
eported in at least 1/3 studies. Ranked frequencies of the mosts included in the analysis.
often reported structures are given (blue in Fig. 4). Interestingly
amygdala activation is reported in less than 5% of experiments.
The CBMA of CP studies revealed clusters of activation in 15
structures: bilateral thalamus, bilateral INS, left S2, left dorsal
ACC (BA32), bilateral precentral (BA6&BA44) and postcentral gyri
(BA40), rightmedial frontal gyrus (MFG), bilateral basal ganglia and
left anterior cerebellum (Fig. 2b, Table S2.2).
The frequency plot (Fig. 4, red) depicts the most often reported
activation sites inCP: the right posterior insula (BA13)was themost
frequently reported (63% of all CP studies) followedby the left BA13
and the bilateral inferior parietal lobule (S2; BA40) in 37–50% of all
studies. Bilateral putamen was reported by 34% of all CP studies.
3.3. Does the neural pain response pattern differ between CP and
HC?
CBMA in both HC and CP groups revealed similar clusters.
No signiﬁcant spatial differences in the activation pattern were
found by CMA. However, there was a trend towards a signiﬁcant
difference just beyond the FCDR threshold (CP>HC, FCDR=0.13)
in the left supramarginal gyrus (BA40). A comparison using the
omnibus test suggested subtle global differences reaching signif-
icance (p=0.048).
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We qualitatively compared the structures reported as activated
n both groups (HC and CP) using a frequency plot (Fig. 4), and
oticed that both groups reported activated structures with rel-
tively similar frequencies.
While no statistically signiﬁcant spatial differences in activation
atterns were detected, this does not rule out the possibility that
here are consistent spatial activation intensity differences. There-
ore, MAC of reported comparisons of CP and HC (CP activation>HC
ctivation, subgroup CP HCMAC; Table 2)was performed, which did
ot reveal any signiﬁcant clusters of activation intensity difference.
n all but two of the included studies, the painful stimulation was
pplied to another part of the body thatwas remote from the site of
linical pain in the CP subjects. An additional MAC of hyperalgesia
s. normalgesia condition within CP subjects (HYPER CPMAC) was
lso non-signiﬁcant but only included three studies.
Due to the potential inhomogeneity introduced by the different
ain stimulus modalities, we also compared HC and CP subgroups
ncluding only studies of mechanical pain stimulation (subgroups
ECHHC andMECHCP; Table 1); this resulted in the largest possible
28 vs. 22 studies respectively) modality speciﬁc subgroup analy-
es. No signiﬁcant differences were found by either CMA below an
ig. 3. Coordinate based meta-analysis of signiﬁcant aggregated contrasts between co
igniﬁcant difference of activation likelihood maps between stimulation sites [most painftion showing signiﬁcant activation likelihood maps [pain activation] for healthy
FCDR of 0.1, and the omnibus test of difference was not signiﬁcant
(p=0.79).
In line with our hypothesis of higher personal relevance of pain
stimulation of the most painful clinically affected body part we
compared the CSCP and OSCP subgroups. The CMA CSCP vs. OSCP
revealed four clusters of more likely activation in the CSCP group
(left putamen; right posterior INS, right mid-INS and left middle
frontal gyrus, Fig. 3b), and one cluster of more likely activation in
the OSCP group (precentral gyrus, Fig. 3b, Tables 2.3–2.5). The fre-
quency plots of reported structures in the two CP sub-groups, and
HC, are displayed in Fig. S1. Left putamen was reported by 50% of
the CSCP studies, 19% of the OSCP studies and 28% of the HC studies.
3.3.1. Is functional reorganisation in CP limited to neuropathic
pain?
We analysed by CBMA the neural signature of pain in neu-
ropathic pain patients (subgroup NEURCP; Table 1), chronic
conditions involving MSK pain (subgroup MSKCP; Table 1), and FM
(subgroup FMCP; Table 1). The cerebral structures consistently acti-
vated in the three subgroups were not signiﬁcantly different either
by CMA or the omnibus test of difference (p>0.05). Findings were
ndition [pain activation during hyperalgesia >normalgesia] (MAC, a, green) and
ul clinically affected (CS) > other site (OS)] (CMA b, red (CS>OS), blue (OS>CS)).
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Fig. 4. Frequency of reported structures in HC (blue) and CP (red) groups. Structures reported at least by 10% of the studies in HC group are displayed (For interpretation of
the references to color in this ﬁgure legend, the reader is referred to the web version of this article.).
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lso not signiﬁcant when including FM in the neuropathic pain
roup.
.3.2. Can functional reorganisation in CP be modelled by
yperalgesia in HC?
The pain activation pattern in a model of peripheral and cen-
ral sensitisation (experimental hyperalgesia in healthy controls,
ubgroup HYPERHC, Table 1) is displayed in green in Fig. 2c. It
hows activations in left thalamus, bilateral INS, right dorsal ACC
BA32), right superior frontal gyrus and the left lentiform nucleus
Table S2.6). The frequency plots of reported structures activated
y experimental hyperalgesia inHC are displayed in Fig. S2. Of note,
eft putamen was reported by 33% of HYPERHC studies.
The CMA of hyperalgesia vs. normalgesia in HC did not elicit
igniﬁcant local or diffuse differences (omnibus test: p=0.7).
.3.3. MAC of hyperalgesia vs. normalgesia in HC
Contrast data comparing experimental pain induced in the pres-
nce of hyperalgesia and experimental pain induced in normal
ondition (normalgesia) was available for extraction in eleven
tudies of which six used stimulus matched comparison (sub-
roup HYPERMAC, Table 2). MAC indeed revealed amultifocal effect
f hyperalgesia on brain activation with signiﬁcant clusters of
ncreased activation in the dorsal ACC (BA32), bilateral INS (BA13),
eft insula (BA40), right IPL (S2, BA40), right middle frontal gyrus
BA9), and left striatum (Fig. 3a, Table S2.7). The activation pat-
ern is highly similar to the pain signature revealed by CBMA of
he CP and HC groups (Fig. 2a and b). These results suggest that
yperalgesia increases activation intensity in many of the known
ain processing areas compared to normalgesia which may in part
eﬂect the experimental design of stimulus intensity rather than
erceptionmatching in ﬁve studies. Nevertheless, when inspecting
he paradigms of those studies contributing to signiﬁcant clusters
erception-based matching designs contributed to all clusters.
It should be noted however, that at least two of four studies
from the same centre) contributed to all of the signiﬁcant clus-
ers that possibly contain overlapping subject samples (Maihofner
nd Handwerker, 2005; Maihofner et al., 2004; Seifert et al., 2008;
eifert and Maihofner, 2007). As this could not be proved conclu-
ively, no study was excluded.
.3.4. Can functional reorganisation in CP be modelled by low
ood in HC?
MAC comparing experimental pain induced in the presence of
ow mood and experimental pain induced in the absence of low
ood included data from only ﬁve studies (subgroup LM HCMAC,
able 1). MAC did not detect regions of consistently increased or
ecreased activation in the presence of low mood. Activation foci
or the low mood condition were only reported seperately in one
tudy so no CBMA was possible.
. Discussion
Coordinate based meta-analysis of 266 cutaneous pain fMRI
tudies demonstrated remarkably similar patterns with no sig-
iﬁcant spatial differences in nociceptive processing across all
onditions of pain stimulation in chronic pain compared to healthy
ontrols in normalgesia as well as after induced hyperalgesia. The
ubgroup of studies applying painful stimuli to the most painful
linically affected body part in CP, however, revealed that activa-
ion was signiﬁcantly more likely in the left putamen, right mid
nd posterior insula and left middle frontal gyrus than if nocicep-
ive stimuli are applied elsewhere. In contrast, there were no local
ifferences in likelihoodofactivationbetweenexperimentalhyper-
lgesia and normalgesia but activation intensity was upregulatedhavioral Reviews 68 (2016) 120–133 129
in many of the pain processing areas including left anterior medial
striatum and bilateral insula.
The cutaneous pain fMRI response pattern was very similar in
healthy controls and chronic pain patients, and no spatial differ-
ence was detected by contrast meta-analysis; a ﬁnding reﬂected in
the similarity of the per-structure activation report frequencies for
the two groups. This ﬁnding was unexpected as functional studies
are commonly referenced to evidence nociceptive neuroplasticity
in chronic pain. The lack of a consistent shift of the spatial represen-
tation of nociceptive processing in clinical pain patients vs. controls
is in stark contrast to previous coordinate based meta-analyses
(Friebel et al., 2011; Lanz et al., 2011) that, however, contradict
each other. Lanz et al. reported signiﬁcantly more likely activated
S2, contralateral SMAand ipsilateral cerebellum in patients vs. con-
trols, but less likely activation in S1, insula, ACC, PFC, thalamus and
cerebellum. By contrast, Friebel reported stronger convergence of
activation in the left supramarginal gyrus, right anterior insula and
left ACC in patients and reduced activation likelihood in the left
posterior, right anterior insula, right SMA and S2. These discrep-
ancies can be explained by methodological differences: Lanz et al.
used a null hypothesis that coordinates were randomly distributed
(Laird et al., 2005), while Friebel et al. used amore appropriate per-
mutation of the grouping variable, but did not correct for multiple
voxel-wise statistical tests. Another important limitation of previ-
ous pain CBMAs is lack of consideration for the correlation between
coordinates reported by similar experiments using the same sub-
jects; it is important that these coordinates are not treated as
independent (Turkeltaub et al., 2012). Indeed, when rerunning the
CBMA without appropriate merging, eight clusters were detected
comparing the CP and HC groups (data not shown). Therefore, pre-
viously reported group differences might be explained by lack of
rigorous data merging as required for any meta-analysis, or by
inadequate statistical methodology.
Regardless of the appropriateness of statistical inferencesmade,
CMA can only test for consistent differences in the pattern of
reported activation between groups, and not for possible differ-
ences in activation intensity within shared activations. This can
be addressed by aggregating reported activation foci detected by
studies comparing groups, such as HC and CP. MAC of data from
eighteen eligible studies did not reveal spatially consistent acti-
vation intensity differences between CP and healthy controls. Five
pain fMRI studies comparing CP and HC failed to show signiﬁcant
results on direct comparison of the CP andHC groups. Furthermore,
seven studies did not report the results of comparison between
these groups. It is conceivable that this represents apublicationbias
as authors might have refrained from undertaking between group
comparison due to expected low power or from reporting negative
results, which either way would be in line with the negative MAC
result.
Failure to observe a consistent localised differential activa-
tion pattern across the studied populations and experimental
designs does not exclude possible subtle widespread differences
in activation pattern, or differences limited to speciﬁc patient sub-
groups or experimental settings; for example a systematic anterior
shift of insular activation was reported for neuropathic patients
(Schweinhardt and Bushnell, 2010). Also, a recent detailed anal-
ysis demonstrated plasticity of the somatosensory system only
in patients with chronic neuropathic pain (Gustin et al., 2012).
Therefore, we additionally tested for global differences in the
activation pattern between groups, and subgroups, using a more
sensitive omnibus test (Tench et al., 2014). This suggested a sub-
tle global differences across activation patterns between the HC
and CP (p=0.048). Importantly, functional reorganisation is likely
moderated by pain etiology and phenotype, but the neuropathic
and nociceptive subgroups were not detectably different from the
HC group. Furthermore, there is some uncertainty how to classify
1 Biobe
p
i
p
2
f
a
h
p
b
w
e
c
l
r
p
t
b
p
p
t
d
v
o
n
l
p
s
S
n
p
b
t
d
a
a
p
d
2
m
m
m
1
M
a
d
i
a
f
v
e
w
e
r
a
t
a
b
i
w
a
n
a
r30 R. Tanasescu et al. / Neuroscience and
atients with ﬁbromyalgia (FM), and individual pain fMRI stud-
es suggested hyperactivation of the insula which might reﬂect the
ostulated multisensory sensation syndrome in FM (Gracely et al.,
002). However, no differences between the subgroup of eight pain
MRI studies in FM and healthy controls were detected.
The experimental conditions are known to affect the pattern
nd intensity of fMRI response in healthy controls, so it is unclear
ow to best study brain plasticity in CP. Intuitively, eliciting clinical
ain would be most relevant. However, as this is not always possi-
le, we subgrouped CP studies according to whether the stimulus
as applied on the clinically affected body part or remotely. When
xposed to experimental painful stimulation of their most painful
linically affected body part, CP exhibited consistently higher like-
ihood of activation in the left putamen, left middle frontal gyrus,
ight posterior andmid INS. Post hoc analysis comparing activation
atterns on clinical site stimulation tohealthy controls revealed the
womost signiﬁcant stuctureswere the left putamen and right INS,
ut these were not signiﬁcant after correction for multiple com-
arisons. This is also suggested by the frequency plots showing
utaminal activation in 28% of HC pain fMRI studies in contrast
o 50% in CP exposed to nociception of the affected body part. We
id not identify any other experimental factor (painmodality, cued
s. non cued, control condition) predicting the increased likelihood
f putaminal activation.
The putamen is not considered part of the common neural sig-
ature of pain, with its main function being motor and implicit
earning. Recently, however, a compelling case was made that the
utamen may play a key role in co-ordinating nociceptive, sen-
ory and cognitive-emotional pain processing (Starr et al., 2011).
uch a role is foremost supported by the anatomical connected-
ess of the putamen; probabilistic tractography revealed that the
utamen is not only interconnected with sensori-motor circuits
ut also nociceptive and attention areas including ACC, INS and
halamus, emotional and memory networks including the amyg-
ala, hippocampus and substantia nigra (SN)/ventral tegmental
rea (VTA) (Starr et al., 2011). SN and VTA both receive direct
fferent nociceptive information from the spinal cord via the
arabrachial nucleus in the midbrain, and activate the putamen
uring pain (Bernard and Besson, 1990; Craig, 1995; Klop et al.,
005; Schneider, 1986;Vankovaet al., 1992). Importantly, theputa-
en can shape activity in large areas of cortex via differentially
odulating the levels of inhibition into the thalamus in both ani-
als and humans (Alexander and Crutcher, 1990; Alexander et al.,
990; Chevalier and Deniau, 1990; Middleton and Strick, 2000;
ufson andMesulam, 1984; Vogt et al., 1987).Mechanistic support
lso comes from a study in patients with putamenal lesions who
emonstrateddecreasedpain sensitivity andwidespreaddecreases
n pain-related brain activation (Starr et al., 2011).
We propose that the putamen plays a speciﬁc role in the mal-
daptive state of chronic pain related to affective learning. Several
unctional neuroimaging studies showed putaminal/striatal acti-
ation in aversive learning (Delgado et al., 2008), disgust (Phillips
t al., 1997), and hate (Zeki and Romaya, 2008). Putamen activation
as also directly linked to learning of pain-related fear (Pohlack
t al., 2012), with co-activation during early acquisition even in a
apid conditioned aversive learning paradigm using visceral pain
s an unconditioned stimulus (Gramsch et al., 2014). A link of
he observed increased putaminal activation in CP with aversive
ffective learning is also in line with recently reported coordinate
ased meta-analysis of fMRI studies on emotion regulation ﬁnding
ncreased striatal activation during emotional upregulation, which
as interpreted to be reﬂective of its role in affective learning
nd the initial stages of action preparation (Frank et al., 2014). Of
ote, most of the studies included in Frank et al. involve unpleas-
nt stimuli, (Frank et al., 2014). The observed modiﬁed putaminal
esponse to pain stimulation of clinically affected body parts mighthavioral Reviews 68 (2016) 120–133
thus reﬂect implicit aversive learning and consecutive enhanced
affective regulation (Baliki and Apkarian, 2015).
Intriguingly, putamen activation is an emerging hallmark of
spontaneous pain processing in clinical pain as assessed by PET
(Kulkarni et al., 2007) and arterial spin labelling (Howard et al.,
2011; Kulkarni et al., 2007; Liu et al., 2013). These studies con-
sistently reported increased blood ﬂow and metabolism indexing
neural activity in the left putamen in patients with on-going pain.
Further supporting a key role for the putamen in pain augmen-
tation comes from the observation of high incidence of pain in
Parkinson’s characterised by putaminal dopaminergic denerva-
tion (Ford, 1998), putaminal dopaminergic deﬁcit in chronic pain
patients (Jaaskelainen et al., 2001), and an inverse link between D2
receptors and dopamine availability and pain sensitivity in healthy
controls (Hagelberg et al., 2004). Taken together with our ﬁndings
this provides evidence for a previously unrecognised key role of
the putamen in maladaptive neuroplasticity in the chronic pain
state, which is likely to reﬂect emotional upregulation. Our ﬁnd-
ing of modiﬁed putamen activity linked to pain stimulation of the
affected body part highlights that functional reorganisation in CP
is site-sepeciﬁc. This could possibly result from local and regional
sensitisation aswell as conditional augmentationwhich is depend-
ent upon it’s contextual relevance in line with implicit aversive
learning.
Noxious stimulation at the most painful clinically affected site
in CP also inducedmore right posterior INS activation, which likely
reﬂects CP induced hyperalgesia. In fact, the posterior insula is the
most consistently reported brain activation site across all pain con-
ditions and groups (frequency plots). This is in line with direct
stimulation experiments showing that pain perception can only
be elicited from the posterior insula (Ostrowsky et al., 2002). Our
result concords with recent evidence for a close correlation of pain
perceptionwith regional blood ﬂow increase in the posterior insula
(Segerdahl et al., 2015). Posterior INS also encodes intensity of
a pain stimulus (Frot et al., 1991) and is hence a plausible neu-
ral correlate of hyperalgesia. Peripheral and central sensitisation
are increasingly recognised not only in neuropathic but also pri-
mary nociceptive chronic pain syndromes such as OA, leading to
local and, to a lesser extent, remote hyperalgesia evidenced by
reduced pain thresholds (Suokas et al., 2012). Given the core role of
the posterior insula for pain perception, increased activation likely
reﬂects hyperalgesia in chronic pain. Moreover, INS activation cor-
relates with unpleasantesness of thermal hyperalgesia (Maihofner
and Handwerker, 2005) and is involved in modulation of the affec-
tive aspect of sensory perception by pain expectation (Sawamoto
et al., 2000). Multiple functional associations have been reported
for the middle frontal gyrus (BA9), including attention to negative
emotional stimuli (Kerestes et al., 2012). Interstingly, BA9 was also
signiﬁcantly more likely to be activated in clinical site vs. other site
pain stimulation.
A main aim of our meta-analysis was to investigate the nature
of maladaptive neuroplasticity in chronic pain using a mechanisti-
cally based approach. Themost popularmodel of pain sensitisation
is experimentally induced transient hyperalgesia in healthy vol-
unteers using capsaicin to reduce pain thresholds locally and
remotely for homo- and heteromodal nociception thus modelling
both peripheral and central sensitisation (Woolf, 2011). Should the
observed increased likelihood of putaminal,middle frontal andmid
and posterior INS activation in CP stimulated at the clinical site be
caused by sensitisation alone, wewould expect a similar difference
toemerge fromexperimentalhyperalgesia. In contrast,we foundno
differences between the aggregate response pattern to cutaneous
noxious stimuli in experimental hyperalgesic vs. normalgesic. The
smallest p value for the left putamen from this CMA (HYPERHC vs
HC) was 0.014, which is far above the threshold for signiﬁcance
after correction for multiple comparisons. This is not surprising, as
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he frequency plots show left putamen and right INS being reported
ith close frequencies by studies in both groups: 33%HYPERHC and
8% in theHCgroup (left putamen); 77%HYPERHC and66% in theHC
right INS). This is again in clear contradiction with previous CMA
ndings that described a higher activation likelihood of bilateral S2
nd prefrontal cortex, right ACC, left basal ganglia and cerebellum
n hyperalgesia/allodynia as well as reduced activation likelihood
f the right insula, left ACC and prefrontal cortex, bilateral thala-
us and bilateral basal ganglia (Lanz et al., 2011). As discussed
bove the fundamental differences in statistical inference explain
he stark differences.
Intriguingly, while we found no spatial differences in the acti-
ation likelihood pattern using CMA, using MAC we found several
lusters of consistently increased activation intensity as a neural
orrelate of central sensitisation. The observed hyperactivity pat-
ern in experimental hyperalgesia includes many pain processing
reas with the mid-left ACC, bilateral insula, right S2, left striatum
n addition to the rightmiddle frontal gyrus. Themost parsimonous
xplanation would thus be that the brain correlate of central
ensitisation is a generalised upregulation of pain processing.
his in turn would be in line with the behavioral hyperalgesia
nd mechanistically with increased nociceptive signalling (Woolf,
011). The pattern also closely resembles regions identiﬁed to
ncode perceived pain intensity (Favilla et al., 2014) including
he salience network (anterior INS and ACC). Increased salience
etwork activation furthermore accords well with the real world
xperience of heightened arousal and cognitive attention in hyper-
lgesia/allodynia induced by sunburn. The lack of altered activation
ikelihood, however, suggests that transient central sensitisation is
nsufﬁcient to induce functional brain reorganisation. Moreover,
he pattern of the neural pain response modulated by experi-
ental cutaneous hyperalgesia is largely dissociated from that in
SCP demonstrating thatexperimentalhyperalgesiadoesnotmimic
europlasticity in clinical pain. Importantly, these dissociations
ast doubt on the validity of experimental hyperalgesia as model
or assessing analgesics for chronic pain conditions (Olesen et al.,
012).
When comparing the hyperalgesia pattern identiﬁed usingMAC
ith the altered activation likelihood pattern in CSCP only remote
imilarities can be noted. From 7 clusters in the hyperalgesia-
ormalgesia contrast, only two clusters showed proximity to the
SCP pattern: the left lentiform nucleus cluster in hyperalgesia
aps adjacent (more medial, anterior and inferiorly) to the left
utamen maximum in CSCP; and secondly the right mid insula
BA13) in hyperalgesia locates anteriorly to the right mid insular
luster of increased activation likelihood in CSCP. Despite the pre-
ominant dissociation of experimental hyperalgesia and CSCP, the
roximity of some activation foci point to possible partially shared
echanisms. Against the background of known pain sensitisation
n both conditions, the different type of pain activation augmen-
ation (increased activation intensity vs. likelihood) in adjacent
egions might reﬂect the dynamics of transient to chronic central
ensitisation. It is intriguing to speculate that regional hyperacti-
ation as demonstrated by a model of central sensitisation over
ime may result in functional reorganisation indexed as increased
ctivation likelihood in chronic pain.
The aggregate cutaneous pain response pattern identiﬁed from
his coordinate based meta-analysis of 266 cutaneous pain fMRI
tudies is conﬁrmatory of previous meta-analysis in healthy sub-
ects reﬂecting the expected multidimensional neural networks
ontributing to the subjective pain experience. The consistently
ctivated brain regions represent the so called neural signature
f pain (Wager et al., 2013), formerly referred to as ‘pain matrix’
Melzack, 2001), and include the sensory nociceptive loop (brain-
tem, S1, S2, posterior insula, thalami), the salience network (ACC,
nterior insula), prefrontal cortex and striatum. None of thesehavioral Reviews 68 (2016) 120–133 131
brain activations are speciﬁc for pain (Iannetti andMouraux, 2010),
but the ﬁne grained neural activation pattern identiﬁed through
machine learning was shown to predict physical pain with 94%
accuracy, and even analysis of activation patterns within single
regions (dorsalACC, anterior INS, S2 andpost INS) achievedonaver-
age better than 75% sensitivity and speciﬁcity (Wager et al., 2013).
This consistent neural signature of pain does, however, not trans-
late into the same consistency of identiﬁed activation foci across
pain fMRI studies included in our analysis. Our frequency plot anal-
ysis that is directly comparable to systematic reviews performed
before advent of coordinate based spatial MA conﬁrms that the
posterior insula (right and left) is the most consistently reported
structure. However, it is noteworthy that more than 1 in 3 fMRI
pain studies do not report activation of the posterior insula. This
highlights a remarkable sensitivity issue of current pain fMRI stud-
ies rather than a genuine variability of pain processing as functional
imaging studies are known for very low statistical power (Button
et al., 2013).
Themain limitations of this coordinate basedmeta-analysis are
the limited number, and heterogeneity, of chronic pain fMRI stud-
ies as well as inconsistent reporting. With 266 studies included
this is one of the largest and arguably most rigorous pain fMRI
CBMA to date in healthy volunteers but numbers in chronic pain
patients and hyperalgesic conditions are lower. In particular, there
were only few cutaneous pain fMRI studies in low mood, which
reported contrasts only, precluding the possibility of mood-related
CMA and preventing ﬁrm interpretation of the negative results of
the low vs. normal mood meta-analysis of contrasts. Importantly,
there is substantial variation across studies in which criteria were
applied to report ‘peak activation’ depending on the analysismeth-
ods used, in particular the thresholds used which varied between
P<0.001uncorrected, FDRandFWEcorrection. This reﬂects the lack
of consensus on standards, use of different software packages and
versions and incomplete reporting in the ﬁeld of functional neu-
roimaging (reviewed by Carp (2012)). Also, only one in ﬁve of the
included studies reported coordinates for functional deactivation
precluding ameta-analysis of this important feature of nociceptive
response. This and the lack of included CBF studies of spontaneous
pain prevent a direct comparison with the meta-analysis reported
by (Peyron et al., 2000),whichwas largely based on PET studies.We
chose to limit ourmeta-analysis to fMRI as strongmethod depend-
ent differences were reported previously (Peyron et al., 2000).
Another important limitation is the incomplete reportingofpain
intensity which results in the inability to control for perceived pain
intensity between subgroups. Nevertheless, in those studies where
the group comparisons were directly reported and extracted (for
the MAC analyses) we found a balanced count of studies using per-
cept or stimulus intensity matched paradigms. As these numbers
were low, additional subgroup analyses were not carried out, Thus
we cannot disentangle the effects of transient central sensitisation
from experimentally designed differences in pain intensity encod-
ing.Wedidnot extract pain anticipatorybrain activity,whichmight
reveal additional CP speciﬁc alterations as therewere so fewstudies
reporting on this in CP cohorts.
We limited this coordinate based meta-analysis to the more
commonlyused cutaneouspain stimuli, and can thusnot generalise
ourﬁndings todeeppain stimulationofmuscleorviscera.Hencewe
also did not include muscle or visceral experimental hyperalgesia,
which conceivably might heighten pain unpleasantness and thus
might more closely match the neural signature of chronic pain.
In general,we found that only aminority of CP studies andnot all
experimental hyperalgesia studies reported results (co-ordinates)
from between condition/group comparisons. This is highly rec-
ommended for future pain fMRI studies as MAC is a powerful
alternative to CMA for several reasons: (i) the direct between
group or condition comparison is an effective way to controlling
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or unwanted heterogeneity resulting from technical and experi-
ental speciﬁcities between studies, (ii) the advantages of careful
atching of case control studies are only preserved inMAC but not
MA, and (iii) MAC is sensitive to differences in activation strength.
urrent drives for publicly available neuroimaging repositorieswill
ave theadditional advantage for largepooled imagebasedanalysis
ith thepotential of further advancesoverCBMA(Salimi-Khorshidi
t al., 2009) provided effective and validated means for controlling
tudy-and scanner speciﬁc bias become available.
. Conclusion
Coordinate based meta-analysis of superﬁcial pain fMRI stud-
es using statistically rigorous methodology revealed remarkably
imilar activation patterns in healthy controls during normal-
esia and hyperalgesia and chronic pain patients. However, we
escribe a consistent pattern of hyperactivation in experimen-
al hyperalgesia as model of transient central sensitisation. Also,
e identiﬁed increased likelihood of left putaminal, right middle
rontal gyrus and mid/posterior insular activation when stimulat-
ng the clinically affected site in CP, which we interpret to reﬂect
europlasticity linked to chronic sensitisation augmented by aver-
ive contextual learning.
ppendix A. Supplementary data
Supplementary data associatedwith this article can be found, in
he online version, at http://dx.doi.org/10.1016/j.neubiorev.2016.
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